Inhibition of neutral endopeptidase augments anaphylactic constriction of guinea pig tracheal smooth muscle.
To determine whether tachykinins participate in antigen-induced constriction of tracheal smooth muscle, we examined the effects of a neutral endopeptidase inhibitor, phosphoramidon, the tachykinin antagonist (D-Pro4, D-Trp7,9,10)-substance P(4-11), and capsaicin-induced tachykinin depletion on the responses to antigen in tracheal rings from ovalbumin-sensitized guinea pigs. In these preparations, the antigen (ovalbumin, 0.1 microgram/ml) produced reproducible and durable constriction of tracheal smooth muscle. Incubation with phosphoramidon (10 min, 10 microM) prior to antigen challenge significantly augmented the magnitude of ovalbumin-induced constriction by 22% after 30 min and by 31% after 45 min. The addition of phosphoramidon at the plateau level of antigen-induced constriction produced a similar, significant increase in the magnitude of the constriction. Following incubation with tachykinin antagonist (D-Pro4,D-Trp7,9,10)-substance P(4-11) (5 microM), the contractile response of the tracheal rings to the antigen was not altered. Furthermore, the addition of phosphoramidon (10 microM) did not significantly affect this contraction. Similarly, neither tachykinin antagonist nor phosphoramidon altered the ovalbumin-induced constriction of the tracheal rings from capsaicin-treated guinea pigs. Based on these findings, we hypothesize that tachykinins or similar broncho-constricting neutral endopeptidase substrates were released from tachykinin-containing nerve endings during immediate hypersensitivity reaction in airways, manifesting a modest and delayed constrictive effect. Following alteration of endopeptidase activity, these substances could modulate the anaphylactic constriction of the airway smooth muscle.
Tudoric
N
N
Department of Anesthesiology, Zablocki Veterans Administration Medical Center, Milwaukee, Wisc.
Coon
R L
RL
Flynn
N M
NM
Bosnjak
Z J
ZJ
D000707:Anaphylaxis / Q000503:physiopathology*; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D005260:Female; D006020:Glycopeptides / Q000494:pharmacology; D006168:Guinea Pigs; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000503:physiopathology; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D013373:Substance P / Q000031:analogs & derivatives; D015320:Tachykinins / Q000037:antagonists & inhibitors / Q000502:physiology*; D014132:Trachea / Q000503:physiopathology*
D006020:Glycopeptides; D015320:Tachykinins; D013373:Substance P; D015260:Neprilysin; D002211:Capsaicin; C008890:phosphoramidon